ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Pharming Group NV

Pharming Group NV (PHGN)

0.946
0.053
(5.94%)
Closed December 28 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.946
Bid
0.942
Ask
0.95
Volume
120,729
0.889 Day's Range 0.9495
0.639 52 Week Range 1.22
Previous Close
0.893
Open
0.8945
Last Trade
740
@
0.941
Last Trade Time
Average Volume (3m)
54,221
Financial Volume
-
VWAP
-

PHGN Latest News

Pharming announces public cash offer to the shareholders of Abliva AB

Pharming announces public cash offer to the shareholders of Abliva AB Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product...

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Pharming announces positive topline data in pediatric clinical trial of leniolisib Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare...

Pharming Group reports third quarter 2024 financial results and provides business update

Pharming Group reports third quarter 2024 financial results and provides business update Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023...

Pharming Group to report third quarter 2024 financial results on October 24

Pharming Group to report third quarter 2024 financial results on October 24 Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR...

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Proof of concept clinical trial will evaluate leniolisib in...

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) For media and investors only Indicated for adult and pediatric patients 12 years of age and older with activated...

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Pharming Group reports second quarter and first half 2024 financial results and provides business update Second quarter 2024 total revenues increased by 35% to US$74.1 million, compared to the...

Pharming Group to report second quarter and first half 2024 financial results on August 1

Pharming Group to report second quarter and first half 2024 financial results on August 1 Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam:...

Pharming Group to participate in June investor conferences

Pharming Group to participate in June investor conferences Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that...

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union Leiden, the Netherlands, May 30, 2024: Pharming Group N.V...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.09110.64327485380.8550.94950.8461069530.88982446DE
40.214529.32330827070.73150.950.696819250.83118974DE
120.213529.14675767920.73250.950.6895542210.79527347DE
260.18624.47368421050.760.95050.639506690.7711069DE
52-0.127-11.83597390491.0731.220.639574750.92180038DE
156-0.232-19.69439728351.1781.3110.639503460.94721756DE
260-0.232-19.69439728351.1781.3110.639503460.94721756DE

PHGN - Frequently Asked Questions (FAQ)

What is the current Pharming Group NV share price?
The current share price of Pharming Group NV is 0.946 €
What is the 1 year trading range for Pharming Group NV share price?
Pharming Group NV has traded in the range of 0.639 € to 1.22 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Z4UreAlpha Tech Corp
2.60 €
(114.70%)
8.05k
510Graphex Group Limited
0.392 €
(106.32%)
16.46k
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M000Vertical Aerospace Ltd
14.50 €
(101.39%)
8.16k
2WOWide Open Agriculture Ltd
0.01 €
(100.00%)
18k
ANLAnalog Devices Inc
9.6728 €
(-95.32%)
1.25k
E3O1Nexoptic Technology Corp
0.007 €
(-62.16%)
12.62k
WWTWater Ways Technologies Inc
0.003 €
(-50.00%)
181.5k
1RR1Rokmaster Resources Corp
0.006 €
(-50.00%)
19k
7CCCheckCap Ltd
1.14 €
(-47.22%)
265
PF8European Lithium Limited
0.024 €
(18.81%)
14.01M
D7GNel ASA
0.2429 €
(-3.07%)
5.39M
RQ0DWave Quantum Inc
9.474 €
(21.03%)
3.1M
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M11First Graphene Limited
0.019 €
(4.40%)
2.5M

Discussion

View Full Feed
dstock07734 dstock07734 2 minutes ago
A clueless minion keeps asking stupid questions.

Did you see Dr. Liau was among the coauthors? Did you see LP withdrew from M2Gen board first before Merck started investing?
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264695
NWBO
exwannabe exwannabe 2 minutes ago
Strongly thinking first quarter… maybe 90%. But that leaves 10% for MHRA decision in 2nd Q. :)
So by the end of Q2 will you admit it is not being approved?
NWBO
100lbStriper 100lbStriper 2 minutes ago
Stokd $NLST If curious (or forgot) how "bias of juror 16" was born, the most detailed sequence of events as told by Samsung...crafty work.

5pg doc
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://storage.courtlistener.com/recap/gov.uscourts.cacd.783923/gov.uscou
NLST
Homebrew Homebrew 2 minutes ago
0 shorts...duh.
https://otce.finra.org/otce/equityShortInterest
PHIL
BullNBear52 BullNBear52 2 minutes ago
Do you think slobbering traders have to wear bibs when they trade?
Huggy Bear Huggy Bear 3 minutes ago
There's nothing intellectual about this property at all.

In fact, the con game being played is more intellectual by design.
HMBL
rickstereo3333 rickstereo3333 3 minutes ago
AND???
SNPW
3331 3331 4 minutes ago
You just sold and lost your $16k investment. Entirely your choice, so stop your whining - man up and BE GONE! Hanging around here and crying won't bring your money back, unless you buy back those shares.
BIEL
bas2020 bas2020 5 minutes ago
I fully expect the manipulating cabal to hold the initial price spike to below $1 (as their paid FUDSters have said). But that will be a temporary pause, with a slight retrace, to shake out weak hands. Then the price will go much higher, especially if there is a follow-on partnership announcement w
NWBO
price_and_volume price_and_volume 6 minutes ago
The previous business failure from 4 years ago?

Your post is from summer of 2020...

You appear to have little awareness of the company, its history, or the history of its CEO (other than what KISSINGER pumps here).

Non-stop "awareness campaigning" doesn't
AHRO
Huggy Bear Huggy Bear 6 minutes ago
You may own a small sliver of it after Foote moves it into his private company, and y'all are all giddy about it.

Which amazes me every time.

And here's the kicker - the patent will never be monetized, it's worthless and only good for conning people like yourself out of
HMBL
Real McCoy Real McCoy 6 minutes ago
Man do you agree this was liquidated as reported or what?
100lbStriper 100lbStriper 7 minutes ago
Stokd $NLST This just filed by Samsung demonstrates how unhappy they are with the results of Scarsi's rulings....as I've been attempting to get across. 🍻
Rushing to file opposition the next day on all their denied motions. 😂
They know exactly how things are going t
NLST
manibiotech manibiotech 7 minutes ago
Exactly
NWBO
Tahoe2468 Tahoe2468 8 minutes ago
HOLO HOLO HOLO SQUEEZE IMMINENT!
https://www.timothysykes.com/news/microcloud-hologram-inc-holo-news-2024_12_19/

HOLO
surfer44 surfer44 8 minutes ago
Live Wire & Can I Sit Next To You Girl

https://youtu.be/9gbMzhe_Wgc
baltimorebullet baltimorebullet 9 minutes ago
It was also a relief when my mom passed.
That might seem harsh to some, but she had a strong sense of self and I think would have voted the same way.
AVXL
TenKay TenKay 10 minutes ago
But HMBL will no longer have the “platform” they are referring to.

It’s interesting that HMBL has not disclosed those details in their filings.

What a convoluted mess…but then I suspect that is by design.
HMBL
Express1 Express1 10 minutes ago
I just don't think you are equipped for otc, seriously your bipolar is an issue with you and I think you should leave.  You have no idea what you are talking about, this stock will shake up the otc in first qtr 2025.  Hopefully you will be gone or get the help you need.  Bipolar and otc investing is
RITE
Tahoe2468 Tahoe2468 10 minutes ago
https://www.timothysykes.com/news/microcloud-hologram-inc-holo-news-2024_12_19/

Ohhhh shit!!!!! 
HOLO
ncstrongman ncstrongman 12 minutes ago
you probably going miss the party
SOBR
Golf4Food Golf4Food 12 minutes ago
Nice finds mang!
dennisdave dennisdave 12 minutes ago
? yes there is a MHRA timeline what the hell are you even talking about? If you have vested your short hopes on the MHRA being bureaucratically delayed forever, you should recheck your bear thesis.
NWBO
100lbStriper 100lbStriper 12 minutes ago
Stokd $NLST On juror16, so it's clear what the issue is and what Smsng invoked to influence Scarsi. SMH

Not only that juror didn't raise hand to questions on past/current litigation & contract disputes. It's that she was sued by Koreans.

Scarsi order—pic1
"S
NLST
dstock07734 dstock07734 12 minutes ago
Should YA II PN, Ltd. have some idea about how close the approval can be?
NWBO

Your Recent History

Delayed Upgrade Clock